Results of international clinical trials with Lioresal.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000613:Aminobutyrates / Q000009:adverse effects / Q000627:therapeutic use*; D001927:Brain Diseases / Q000188:drug therapy; D002722:Chlorobenzenes / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy; D009128:Muscle Spasticity / Q000188:drug therapy*; D010276:Parasympatholytics / Q000009:adverse effects / Q000627:therapeutic use; D013118:Spinal Cord Diseases / Q000188:drug therapy
D000613:Aminobutyrates; D002722:Chlorobenzenes; D010276:Parasympatholytics